HCA Healthcare price target raised to $375 from $359 at Deutsche Bank

Deutsche Bank analyst Pito Chickering raised the firm’s price target on HCA Healthcare to $375 from $359 and keeps a Buy rating on the shares. The company’s May revenues continue to track well with revenue growth of 9.4%, the analyst tells investors in a research note. Combining April and May, the firm believes the trends are tracking at 11.2%. However, it points out that June 2023 comps are the toughest ones of the quarter, hence if April and May revenues continue into June, then revenues would be up 9.8% year-over-year.